Twist Bioscience Corporation Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount
Twist Bioscience Corporation (TWST) had Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount of $0 as of 2025-06-30, per its 10-Q filed 2025-08-04.
Financial Statements › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure › Share-Based Payment Arrangement, Additional Disclosure
us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions · last filed 2025-08-04
- 2025-06-30: Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount $0.00.
- 2025-03-31: Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount $100.00K.
- 2024-12-31: Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount $100.00K.
- 2024-06-30: Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount $300.00K.
| Period end | Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount |
|---|---|
| 2025-06-30 | $0.00 10-Q · filed 2025-08-04 |
| 2025-03-31 | $100.00K 10-Q · filed 2025-05-05 |
| 2024-12-31 | $100.00K 10-Q · filed 2025-02-03 |
| 2024-06-30 | $300.00K 10-Q · filed 2024-08-02 |
| 2024-03-31 | $500.00K 10-Q · filed 2024-05-02 |
| 2023-12-31 | $800.00K 10-Q · filed 2024-02-02 |
| 2023-03-31 | $6.70M 10-Q · filed 2023-05-08 |
| 2022-12-31 | $9.40M 10-Q · filed 2023-02-07 |
| 2022-06-30 | $15.40M 10-Q · filed 2022-08-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BIO-TECHNE Corp (TECH) | United States | $11.379B | 74.68 |
| REPLIGEN CORP (RGEN) | United States | $10.755B | 185.31 |
| Krystal Biotech, Inc. (KRYS) | United States | $10.210B | 45.56 |
| HALOZYME THERAPEUTICS, INC. (HALO) | United States | $13.083B | 21.59 |
| Kymera Therapeutics, Inc. (KYMR) | United States | $9.631B | -31.69 |
| ImmunityBio, Inc. (IBRX) | United States | $9.157B | -9.29 |
| NEUROCRINE BIOSCIENCES INC (NBIX) | United States | $14.131B | 24.25 |
| EXELIXIS, INC. (EXEL) | United States | $14.358B | 16.15 |
| Vaxcyte, Inc. (PCVX) | United States | $8.466B | -7.91 |
| Immunovant, Inc. (IMVT) | United States | $7.028B | -14.78 |